Concepedia

Samuel J. Taylor

SJ

Statistics

Publications

16

Citations

494

H-Index

12

Active since

1987

Affiliations

Albert Einstein College of Medicine(Current)

The University of Western Australia

Montefiore Medical Center

University of Manchester

Queen Elizabeth II Medical Centre

Samuel J. Taylor is an author at Albert Einstein College of Medicine specializing in medicine, molecular oncology, and life sciences.

ORCID

Publications per year

1987–2024

16

Publications

16

IL1RAP potentiates multiple oncogenic signaling pathways in AML

Kelly Mitchell, Laura Barreyro, Tihomira I. Todorova et al. · The Journal of Experimental Medicine · 2018 · 95 citations · Full text

, , +14

The DNA dioxygenase Tet1 regulates H3K27 modification and embryonic stem cell biology independent of its catalytic activity

Stephanie Chrysanthou, Qin Tang, Joun Lee et al. · Nucleic Acids Research · 2022 · 65 citations · Full text

, , +17

Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib

Samuel J. Taylor, Johanna M. Duyvestyn, Samantha A. Dagger et al. · Science Translational Medicine · 2017 · 46 citations · Full text

, , +12

Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling

Samuel J. Taylor, Samantha A. Dagger, Christine B.F. Thien et al. · Blood · 2012 · 40 citations · Full text

, , +10

Growth Factors With Heparin Binding Affinity In Human Synovial Fluid

David Hamerman, Samuel J. Taylor, Ira H. Kirschenbaum et al. · Experimental Biology and Medicine · 1987 · 38 citations

, , +15

1–5 of 16